Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
By M. Herdman, C. Gudex, Andrew Lloyd, M. F. Janssen, Paul Kind, D. Parkin, G. Bonsel, Xavier Badia. Quality of Life Research, 2011
8,233 citations recorded by the source corpus.
PurposeThis article introduces the new 5-level EQ-5D (EQ-5D-5L) health status measure.MethodsEQ-5D currently measures health using three levels of severity in five dimensions. A EuroQol Group task force was established to find ways of improving the instrument’s sensitivity and reducing ceiling effects by increasing the number of severity levels. The study was performed in the United Kingdom and Spain. Severity labels for 5 levels in each dimension were identified using response scaling. Focus groups were used to investigate the face and content validity of the new versions, including hypothetical health states generated from those versions.ResultsSelecting labels at approximately the 25th, 50th, and 75th centiles produced two alternative 5-level versions. Focus group work showed a slight preference for the wording ‘slight-moderate-severe’ problems, with anchors of ‘no problems’ and ‘unable to do’ in the EQ-5D functional dimensions. Similar wording was used in the Pain/Discomfort and Anxiety/Depression dimensions. Hypothetical health states were well understood though participants stressed the need for the internal coherence of health states.ConclusionsA 5-level version of the EQ-5D has been developed by the EuroQol Group. Further testing is required to determine whether the new version improves sensitivity and reduces ceiling effects.
Subfields: Economics and Econometrics, General Health Professions
View Paper: https://www.semanticscholar.org/paper/eac9c263d99f397dfc2518ac55f610130aac32a7
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Economics and Econometrics
Citations in the corpus
- Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. (2012, methodology): “Furthermore, intercountry results from the United Kingdom and Spain showed that the 5L labels performed substantially similarly on the response scaling task [3].”
- Dutch Tariff for the Five-Level Version of EQ-5D. (2016, methodology): “improvement over the previous EQ-5D [1,6,7].”
- Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study (2012, methodology): “In developing the 5L, the five-dimensional structure of the 3L was retained, but the descriptors within each dimension were adapted to a 5-level system based on qualitative and quantitative studies conducted by the EuroQol group [19].”
- Valuing health‐related quality of life: An EQ‐5D‐5L value set for England (2017, methodology): “A new version of the instrument, the EQ‐5D‐5L, was developed to improve sensitivity and to standardise the language used across dimensions (Herdman et al., 2011).”
- Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer. (2019, background): “The EQ-5D-5L measures the patient’s perceived health state in the following five domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.(5) Each domain has five possible levels: no problems (level 1), slight problems (level 2),”
- SWOT analysis applications: An integrative literature review (2021, methodology): “Survey questionnaires are also widely used in SWOT studies (Dawes, 2002; Herdman et al., 2011; Hjermstad et al., 2011; Preston & Colman, 2000).”